Prothena Corp. Plc (PRTA)
8.16
-0.07
(-0.85%)
USD |
NASDAQ |
Nov 13, 16:00
8.155
0.00 (0.00%)
Pre-Market: 19:59
Prothena Enterprise Value : 153.83M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 153.83M |
| November 12, 2026 | 157.42M |
| November 11, 2026 | 183.09M |
| November 10, 2026 | 174.37M |
| November 09, 2026 | 185.41M |
| November 06, 2026 | 144.08M |
| November 05, 2026 | 139.97M |
| November 04, 2026 | 165.64M |
| November 03, 2026 | 156.40M |
| November 02, 2026 | 160.50M |
| October 30, 2026 | 169.75M |
| October 29, 2026 | 190.80M |
| October 28, 2026 | 202.09M |
| October 27, 2026 | 187.20M |
| October 26, 2026 | 166.15M |
| October 23, 2026 | 155.88M |
| October 22, 2026 | 158.45M |
| October 21, 2026 | 147.16M |
| October 20, 2026 | 171.29M |
| October 19, 2026 | 170.26M |
| October 16, 2026 | 163.59M |
| October 15, 2026 | 171.29M |
| October 14, 2026 | 164.61M |
| October 13, 2026 | 164.10M |
| October 12, 2026 | 167.69M |
| Date | Value |
|---|---|
| October 09, 2026 | 188.74M |
| October 08, 2026 | 176.93M |
| October 07, 2026 | 170.26M |
| October 06, 2026 | 146.64M |
| October 05, 2026 | 159.48M |
| October 02, 2026 | 164.10M |
| October 01, 2026 | 173.34M |
| September 30, 2026 | 165.13M |
| September 29, 2026 | 173.11M |
| September 28, 2026 | 170.01M |
| September 25, 2026 | 147.76M |
| September 24, 2026 | 149.31M |
| September 23, 2026 | 167.94M |
| September 22, 2026 | 183.98M |
| September 21, 2026 | 159.14M |
| September 18, 2026 | 162.76M |
| September 17, 2026 | 156.55M |
| September 16, 2026 | 145.17M |
| September 15, 2026 | 149.83M |
| September 14, 2026 | 177.25M |
| September 11, 2026 | 180.87M |
| September 10, 2026 | 185.53M |
| September 09, 2026 | 200.02M |
| September 08, 2026 | 212.44M |
| September 04, 2026 | 226.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alkermes Plc | 8.718B |
| Amarin Corp. Plc | -78.32M |
| Agenus, Inc. | 487.93M |
| Amgen, Inc. | 292.70B |
| Anika Therapeutics, Inc. | 160.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.51M |
| Revenue (Quarterly) | 0.62M |
| Total Expenses (Quarterly) | 17.13M |
| EPS Diluted (Quarterly) | -0.321 |
| Gross Profit Margin (Quarterly) | -50.00% |
| Profit Margin (Quarterly) | -2.66K% |
| Earnings Yield | -5.81% |
| Normalized Earnings Yield | -6.490 |